| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
106,150 |
91,328 |
$16.43M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
37,227 |
32,742 |
$5.70M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
16,150 |
13,916 |
$2.53M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,161 |
2,917 |
$561K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
1,876 |
1,718 |
$332K |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
10,935 |
8,959 |
$285K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,512 |
1,479 |
$249K |
| D0999 |
Unspecified diagnostic procedure, by report |
287 |
268 |
$90K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
552 |
521 |
$88K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
579 |
498 |
$80K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
443 |
439 |
$78K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
272 |
267 |
$48K |
| 0001A |
|
2,428 |
2,311 |
$42K |
| 0002A |
|
2,355 |
2,277 |
$41K |
| 36416 |
|
31,214 |
25,940 |
$35K |
| 0502F |
|
1,197 |
826 |
$32K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
431 |
381 |
$23K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
16,505 |
15,232 |
$19K |
| 0012A |
|
774 |
731 |
$13K |
| 90686 |
|
1,788 |
1,649 |
$12K |
| 0011A |
|
757 |
717 |
$12K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
70 |
70 |
$12K |
| 0072A |
|
234 |
227 |
$11K |
| 59409 |
Vaginal delivery only (with or without episiotomy and/or forceps) |
16 |
12 |
$9K |
| 3008F |
|
56,652 |
50,110 |
$9K |
| 0071A |
|
215 |
199 |
$7K |
| G2025 |
Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only |
2,085 |
1,720 |
$7K |
| 99385 |
|
40 |
31 |
$6K |
| 87428 |
|
3,222 |
3,087 |
$6K |
| 1000F |
|
3,120 |
2,624 |
$5K |
| 99383 |
|
28 |
25 |
$5K |
| 3725F |
|
20,857 |
18,142 |
$4K |
| 92015 |
Determination of refractive state |
1,723 |
1,548 |
$4K |
| 99442 |
|
13 |
12 |
$3K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
16 |
16 |
$3K |
| 99460 |
|
28 |
27 |
$3K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,190 |
2,131 |
$2K |
| 99215 |
Prolong outpt/office vis |
17 |
13 |
$2K |
| 90688 |
|
1,022 |
941 |
$2K |
| 0124A |
|
24 |
20 |
$2K |
| 81003 |
|
21,038 |
15,598 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
13 |
12 |
$2K |
| 99381 |
|
12 |
12 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,897 |
2,708 |
$2K |
| 87430 |
|
8,620 |
8,185 |
$2K |
| 3074F |
|
11,082 |
9,328 |
$1K |
| 0031A |
|
88 |
83 |
$1K |
| 11981 |
|
15 |
12 |
$1K |
| 0003A |
|
35 |
34 |
$1K |
| 90715 |
|
480 |
440 |
$846.72 |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
14 |
13 |
$766.20 |
| D0140 |
Limited oral evaluation - problem focused |
58 |
57 |
$635.94 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
30,833 |
27,224 |
$578.65 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
59 |
57 |
$536.31 |
| 0013A |
|
24 |
21 |
$488.26 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
6,433 |
5,880 |
$485.59 |
| 0004A |
|
15 |
15 |
$470.62 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
10,654 |
5,457 |
$451.75 |
| D1110 |
Prophylaxis - adult |
36 |
36 |
$302.61 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,727 |
3,554 |
$302.54 |
| D0220 |
Intraoral - periapical first radiographic image |
62 |
61 |
$259.00 |
| D0150 |
Comprehensive oral evaluation - new or established patient |
13 |
13 |
$203.05 |
| 92551 |
|
785 |
769 |
$190.07 |
| 90677 |
|
138 |
136 |
$121.72 |
| 90723 |
|
13 |
13 |
$116.81 |
| 85018 |
|
5,240 |
4,232 |
$98.66 |
| D0120 |
Periodic oral evaluation - established patient |
25 |
25 |
$91.30 |
| 81025 |
|
2,193 |
1,989 |
$59.43 |
| 92250 |
|
246 |
233 |
$38.71 |
| 82962 |
|
10,653 |
9,010 |
$34.64 |
| 99173 |
|
906 |
834 |
$30.82 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
68 |
63 |
$12.00 |
| 87400 |
|
68 |
63 |
$9.89 |
| 3079F |
|
1,804 |
1,577 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
509 |
481 |
$0.00 |
| 3044F |
|
310 |
297 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
227 |
217 |
$0.00 |
| 87280 |
|
407 |
398 |
$0.00 |
| G9226 |
Foot examination performed (includes examination through visual inspection, sensory exam with 10-g monofilament plus testing any one of the following: vibration using 128-hz tuning fork, pinprick sensation, ankle reflexes, or vibration perception threshold, and pulse exam; report when all of the 3 components are completed) |
16 |
15 |
$0.00 |
| 90474 |
|
39 |
38 |
$0.00 |
| 3075F |
|
312 |
279 |
$0.00 |
| 96127 |
|
15 |
13 |
$0.00 |
| 81001 |
|
125 |
110 |
$0.00 |
| 1111F |
|
12 |
12 |
$0.00 |
| 90647 |
|
26 |
26 |
$0.00 |
| 90480 |
|
18 |
18 |
$0.00 |
| 90716 |
|
56 |
55 |
$0.00 |
| 90651 |
|
20 |
17 |
$0.00 |
| 90744 |
|
14 |
14 |
$0.00 |
| 3078F |
|
9,917 |
8,387 |
$0.00 |
| 80305 |
|
1,244 |
1,084 |
$0.00 |
| 90473 |
|
348 |
336 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
985 |
919 |
$0.00 |
| 87210 |
|
534 |
514 |
$0.00 |
| 90633 |
|
21 |
20 |
$0.00 |
| J7307 |
Etonogestrel (contraceptive) implant system, including implant and supplies |
15 |
12 |
$0.00 |
| 90713 |
|
103 |
100 |
$0.00 |
| 90746 |
|
29 |
28 |
$0.00 |
| 3077F |
|
27 |
26 |
$0.00 |
| 59025 |
Fetal non-stress test |
86 |
62 |
$0.00 |
| 81002 |
|
21 |
18 |
$0.00 |
| 90707 |
|
14 |
14 |
$0.00 |